← Leaderboards
Rando L Allikmets
Columbia University Health Sciences
$26,307,408
Attributed
$26,307,408
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,307,408 · 9
By mechanism
R01$17,992,478 · 6
R24$7,246,202 · 1
P30$1,068,728 · 2
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Janet R. Sparrow$21,221,236
- Christiane Reitz$17,861,730
- Richard Mayeux$113,943,785
- Livio Pellizzoni$13,515,447
- Isabelle Audo$3,637,126
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticVariantPhenotypeProgramsMutationAffectGenesGenotypeCohortAllelesGenetic AnalysisGenetic DatabasesDesignClinical TrialsOutcome StudyStargardt&AposRetinitis PigmentosaRetinal DiseasesS DiseaseRetinaBaseClinical DataFamilyGene Expression
Grant awards (44)
Stargardt/ABCA4 disease in African Americans$601,683
R01 · FY2025 · EY · contact PI
Stargardt/ABCA4 disease in African Americans$650,058
R01 · FY2024 · EY · contact PI
Computer Core$267,182
P30 · FY2024 · EY · contact PI
Integrated clinical, genetic and functional analysis of the ABCA4 locus$433,832
R01 · FY2023 · EY · contact PI
Computer Core$267,182
P30 · FY2023 · EY · contact PI
Stargardt disease with low lipofuscin$508,519
R01 · FY2022 · EY · contact PI
Integrated clinical, genetic and functional analysis of the ABCA4 locus$420,816
R01 · FY2022 · EY · contact PI
Computer Core$267,182
P30 · FY2022 · EY · contact PI
Precision medicine for ABCA4 disease: modifier alleles$573,537
R01 · FY2021 · EY · contact PI
Stargardt disease with low lipofuscin$508,519
R01 · FY2021 · EY · contact PI
Integrated clinical, genetic and functional analysis of the ABCA4 locus$420,815
R01 · FY2021 · EY · contact PI
Computer Core$267,182
P30 · FY2021 · EY · contact PI
Precision medicine for ABCA4 disease: modifier alleles$591,277
R01 · FY2020 · EY · contact PI
Stargardt disease with low lipofuscin$533,157
R01 · FY2020 · EY · contact PI
Integrated clinical, genetic and functional analysis of the ABCA4 locus$450,842
R01 · FY2020 · EY · contact PI
Precision medicine for ABCA4 disease: modifier alleles$591,277
R01 · FY2019 · EY · contact PI
Stargardt disease with low lipofuscin$533,157
R01 · FY2019 · EY · contact PI
Integrated clinical, genetic and functional analysis of the ABCA4 locus$466,342
R01 · FY2019 · EY · contact PI
Precision medicine for ABCA4 disease: modifier alleles$591,277
R01 · FY2018 · EY · contact PI
Therapeutic approaches for ABCA4-associated disorders$1,429,108
R24 · FY2015 · EY · contact PI
Therapeutic approaches for ABCA4-associated disorders$1,433,743
R24 · FY2014 · EY · contact PI
Genetic Susceptibility to Age-Related Macular Degeneration$583,877
R01 · FY2014 · EY · contact PI
Completing genetic analysis of the ABCA4 locus$506,985
R01 · FY2014 · EY · contact PI
Therapeutic approaches for ABCA4-associated disorders$1,438,197
R24 · FY2013 · EY · contact PI
Genetic Susceptibility to Age-Related Macular Degeneration$588,817
R01 · FY2013 · EY · contact PI
Completing genetic analysis of the ABCA4 locus$573,872
R01 · FY2013 · EY · contact PI
Therapeutic approaches for ABCA4-associated disorders$1,442,474
R24 · FY2012 · EY · contact PI
Completing genetic analysis of the ABCA4 locus$644,326
R01 · FY2012 · EY · contact PI
Genetic Susceptibility to Age-Related Macular Degeneration$619,808
R01 · FY2012 · EY · contact PI
Therapeutic approaches for ABCA4-associated disorders$1,502,680
R24 · FY2011 · EY · contact PI
Completing genetic analysis of the ABCA4 locus$659,576
R01 · FY2011 · EY · contact PI
Genetic Susceptibility to Age-Related Macular Degeneration$601,026
R01 · FY2011 · EY · contact PI
Genetic Susceptibility to Age-Related Macular Degeneration$656,943
R01 · FY2010 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$506,607
R01 · FY2009 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$301,555
R01 · FY2009 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$482,016
R01 · FY2008 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$712,029
R01 · FY2007 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$702,053
R01 · FY2006 · EY · contact PI
Genetic Variation in Age-Related Macular Degeneration$463,543
R01 · FY2005 · EY
Genetic Variation in Age-Related Macular Degeneration$60,375
R01 · FY2005 · EY
Genetic Variation in Age-related Macular Degeneration$367,875
R01 · FY2003 · EY
Genetic Variation in Age-related Macular Degeneration$477,932
R01 · FY2002 · EY
Genetic Variation in Age-related Macular Degeneration$367,875
R01 · FY2001 · EY
Genetic Variation in Age-related Macular Degeneration$240,280
R01 · FY2001 · EY